Overview
Lymphatic leukaemia is a disorder. There are currently 1 actively recruiting clinical trials.
Auto-generated from clinical reference data. Not a substitute for medical advice.
Treatments & Interventions
Imatinib mesylate
substance
Rituximab
substance
Teniposide
substance
Clofarabine
substance
Imatinib
substance
Dasatinib
substance
Bendamustine
substance
Bendamustine hydrochloride
substance
Ofatumumab
substance
Idelalisib
substance
Obinutuzumab
substance
Blinatumomab
substance
Venetoclax
substance
Dasatinib anhydrous
substance
Clinical Trials
2
Total Trials
1
Recruiting
1
With Results
Related Conditions
Subacute lymphoid leukemia(child)
Aleukemic lymphoid leukemia(child)
Acute lymphoid leukemia(child)
Chronic lymphoid leukemia(child)
Lymphoid leukemia in remission(child)
Hairy cell leukemia (clinical)(child)
Prolymphocytic leukemia (clinical)(child)
Large granular lymphocytic leukemia(child)
Lymphoid leukemia in relapse(child)
Leukaemia(parent)
Lymphoreticular tumour(parent)
Neoplasm of bone marrow(parent)
Quick Facts
- SNOMED CT
- 188725004
- UMLS CUI
- C0023448
- Fully Specified Name
- Lymphoid leukemia (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Known Treatments
- 14
- Clinical Trials
- 2
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.